Welcome to Chinese Journal of Clinical Pharmacology and Therapeutics,Today is Share:

Chinese Journal of Clinical Pharmacology and Therapeutics ›› 2021, Vol. 26 ›› Issue (2): 204-212.doi: 10.12092/j.issn.1009-2501.2021.02.012

Previous Articles     Next Articles

Advances on pharmacogenomics of diuretics-related adverse reactions

XING Kai 1,2, GONG Jinyu 1,2, LUO Jianquan 1,2   

  1. 1 Department of Pharmacy, the Second Xiangya Hospital of Central South University, Changsha 410011, Hunan, China; 2 Institute of Clinical Pharmacy, Central South University, Changsha 410011, Hunan, China
  • Received:2020-07-20 Revised:2020-09-11 Online:2021-02-26 Published:2021-03-04

Abstract: Diuretics are the first-line drugs for the treatment of hypertension. Long-term use of diuretics often causes elevated blood sugar, electrolyte disturbances (most commonly hypokalemia), abnormal lipid metabolism (such as increased triglycerides, elevated cholesterol), increased serum uric acid levels and so on. In order to clarify the specific mechanism of the adverse reactions related to diuretics which are widely used in the treatment of hypertension, many documents have reported the pharmacogenomics research of diuretics-related adverse reactions. This review discusses the related genes and their variants of adverse reactions caused by commonly used diuretics in the treatment of hypertension in hope of providing a basis for the study of individualized use of diuretics.

Key words: diuretics, hypertension, adverse reactions, pharmacogenomics

CLC Number: